Juan Camilo Arjona Ferreira - Aug 11, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role: Head of R&D & CMO
Signature: /s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira
Stock symbol: OGN
Transactions as of: Aug 11, 2024
Transactions value $: -$80,419
Form type: 4
Date filed: 8/12/2024, 05:18 PM
Previous filing: Apr 16, 2024
Next filing: Nov 8, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise	$0	+11.5K	+86284.64%	$0.00	11.5K	Aug 11, 2024	Direct
transaction	OGN	Common Stock	Tax liability	-$80.4K	-3.99K	-34.61%	$20.15	7.54K	Aug 11, 2024	Direct

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-11.5K	-33.33%	$0.00	23K	Aug 11, 2024	Common Stock	11.5K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Organon common stock.
F2	These restricted stock units vest and are distributed as shares of Organon & Co. common stock in three equal installments of 11,519 shares on each of August 11, 2024; August 11, 2025; and August 11, 2026.